Public Health Conference March 3, 2016.  Recognize the merger of opioid abuse and disease transmission  Identify Missouri opioid abuse data components.

Slides:



Advertisements
Similar presentations
Unintentional Drug Poisoning Deaths, Michigan Residents, Su Min Oh, PhD Michigan Department of Community Health Bureau of Substance Abuse and.
Advertisements

HIV and STD in Maine Data from the Bureau of Health HIV/STD Program Contact: Mark Griswold (207)
The purpose of this overview is to update the facts pertaining to the possibility of upward trends related to heroin trafficking and/or abuse in the Commonwealth.
National Institute on Drug Abuse P rescription D rug A buse: An Escalating Public Health Threat P rescription D rug A buse: An Escalating Public Health.
SOUTH CAROLINA EPIDEMIOLOGIC PROFILE Data available in an Integrated Epidemiologic Profile Core Epi Section Socio-demographic characteristics of.
2.11 Conduct Medication Management University Medical Center Health System Lubbock, TX Jason Mills, PharmD, RPh Assistant Director of Pharmacy.
Rx for Drug-Seeking Patients in the ED The Monterey County Prescribe Safe Initiative 1.
TM Centers for Disease Control and Prevention National Center for Injury Prevention and Control Centers for Disease Control and Prevention National Center.
HIV and Hepatitis C in non- MSM Rural Communities: Issues and Interventions Shari Wells-Weiss, CASAC Director of Prevention Services Southern Tier AIDS.
Recovery Housing and The National Drug Control Strategy David K. Mineta Deputy Director, Demand Reduction Office of National Drug Control Policy (ONDCP)
Prescription Opioid Use and Opioid-Related Overdose Death — TN, 2009–2010 Jane A.G. Baumblatt, MD Centers for Disease Control and Prevention Epidemic Intelligence.
Florida Department of Health HIV/AIDS & Hepatitis Section Annual data trends as of 12/31/2012 Living (Prevalence) data as of 05/16/2012 Epidemiology of.
Serving our community by improving health The Addiction Crisis November 2014.
Research and analysis by Avalere Health The Opportunities and Challenges for Rural Hospitals in an Era of Health Reform April, 2011.
Chronic Pain Initiative CCNC and Project Lazarus: Chronic Pain and Community Initiative.
1 Mental Health and Substance Abuse Services Division Association of Substance Abuse Providers Mike Maples October 5, 2011.
A Cluster of Hepatitis C among Rural, Young Adults – Illinois, 2012 Julia Howland, MPH CPH CDC/CSTE Applied Epidemiology Fellow Illinois Department of.
Sexually Transmitted Disease (STD) Surveillance Report, 2009 Minnesota Department of Health STD Surveillance System Minnesota Department of Health STD.
Sexually Transmitted Infections Mysheika Williams Roberts, MD, MPH Medical Director Assistant Health Commissioner Columbus.
Cancer Healthy Kansans 2010 Steering Committee Meeting May 12, 2005.
Using HIV Surveillance to Achieve High Impact Prevention Irene Hall, PhD, FACE AIDS 2012 High-Impact Prevention: Reducing the HIV Epidemic in the United.
November 2012 Prepared for the Contra Costa Board of Supervisors by Contra Costa Health Department Needle Exchange Update.
1 OPA/OFP HIV Prevention Project Annual Technical Support Conference Six Years of HIV Supplemental Grants – A National Perspective Susan B. Moskosky Director,
2008 Minnesota HIV/AIDS Surveillance Report - Key Trends Lorraine Teel- Executive Director.
An integrated approach to addressing opiate abuse in Maine Debra L. Brucker, MPA, PhD State of Maine Office of Substance Abuse October 2009.
Gonorrhea Morbidity, Missouri, 2008 In 2008, there were 8,014 reported gonorrhea cases. Of these, 57% were in females, 65% were among Black, non-Hispanic.
TB, STDs, HIV, HEPATITIS C and SUBSTANCE ABUSE: A Local Perspective Paula Kriner, MPH Imperial County Public Health Department Management of TB, STDs,
Outbreak of HIV and Hepatitis C Linked to Injection Drug Use in Rural Indiana Panel Presentation APIC Indiana Fall Educational Conference October 9, 2015.
Pennsylvania: The State of HCV 2015
Evaluating the Use of HIV Surveillance Data for Initiating Partner Services in Houston, Texas, US 2012 International AIDS Conference Washington, D.C. Shirley.
Sexually Transmitted Disease (STD) Surveillance Report, 2013 Minnesota Department of Health STD Surveillance System Minnesota Department of Health STD.
Injection Drug Use and Hepatitis C What Can We Do About It? Wilson M. Compton, M.D., M.P.E. Deputy Director National Institute on Drug Abuse.
Hepatitis C: The Silent Epidemic Wednesday, October 21, 2015 John W. Ward, M.D. Division of Viral Hepatitis Centers for Disease Control and Prevention.
Opiate Management Douglas Keehn DO Adjunct Assistant Clinical Professor University Wisconsin Board Certified Anesthesia & Pain Management.
Sexually Transmitted Disease (STD) Surveillance Report, 2008 Minnesota Department of Health STD Surveillance System Minnesota Department of Health STD.
Florida Department of Health HIV/AIDS Section Division of Disease Control and Health Protection Annual data trends as of 12/31/2014 Living (Prevalence)
Jennifer R. Havens, PhD, MPH Associate Professor
Diane M. Janowicz, MD Assistant Professor of Clinical Medicine Indiana University School of Medicine Indianapolis, Indiana Persistent Challenges of HIV.
Reducing Preventable Emergency Room Visits 1. An Opportunity Redirecting care to the most appropriate setting protects patient safety and ensures payment.
The Prescription Opioid and Heroin Crisis: An Epidemic of Addiction The Prescription Opioid and Heroin Crisis: An Epidemic of Addiction Andrew Kolodny,
Mean HIV viral load among resident cases and undiagnosed in Oregon Jeff Capizzi, Epidemiologist Sean Schafer, HIV/STD/TB Medical Epidemiologist Lea Bush,
1 Prescribing Pain Medication – Guidelines for the Emergency Department April 22, 2012 Jennifer Sabel, PhD.
Colleen Brody, Program Supervisor II Pristeen Rickett, Disease Intervention Specialist Elizabeth “Page” Brockwell, Service Chief.
Lessons Learned and Novel Investigation Techniques in Response to a Large Community Outbreak of HIV-1 infection Philip J. Peters MD HIV Testing and Biomedical.
Andrew J Barnes & Rose S Bono Health Behavior and Policy Virginia Commonwealth University Virginia’s Opioid Epidemic and Health Policy.
Community Outbreak of HIV Infection Linked to Injection Drug Use of Oxymorphone — Indiana, 2015 Joan M. Duwve, MD, MPH Chief Medical Officer, Indiana State.
Community Outbreak of HIV Infection Linked to Injection Drug Use of Oxymorphone — Indiana, 2015 Joan M. Duwve, MD, MPH Associate Dean for Public Health.
Lessons from Indiana HIV and Hepatitis C Wisconsin HIV Community Planning Statewide Action Planning Group Meeting Green Lake June 25,
Organizing Drug Users for Public Health Policy Changes 17 th International Conference on the Reduction of Drug Related Harm Jason Farrell, Executive Director.
Diane M. Janowicz, MD Assistant Professor of Clinical Medicine Indiana University School of Medicine Indianapolis, Indiana Persistent Challenges of HIV.
The Prescription Opioid & Heroin Crisis: Addiction & Medication Assisted Treatment Andrew Kolodny, M.D. Chief Medical Officer, Phoenix House Foundation.
Responding to the Opioid Addiction Epidemic Andrew Kolodny, M.D. Chief Medical Officer, Phoenix House Foundation Inc. Executive Director, Physicians for.
Charlie Howsare, MD MPH Pa. Viral Hepatitis Prevention Coordinator
Ryan White Part A & Minority AIDS Initiative Service Utilization in the Indianapolis Transitional Grant Area: FY June 1, 2017 Tammie L. Nelson,
Addressing the Intersection of Substance Abuse and Viral Hepatitis
Opioid Addiction in Tennessee
Nebraska Prescription Drug Overdose Prevention Program Efforts
Medication-Assisted Therapy at Coleman Profession Services
Young People Newly Diagnosed with Hepatitis C in New York City
Understanding the Opioid Epidemic
Jonathan Mermin, MD, MPH RADM, USPHS
National Programme for limiting spread of HIV/AIDS in Latvia 2008–2012
Primary Prevention in the Time of the Opioid Epidemic
Needle exchange program
Opiate Roundtable March 29, 2018 Karen Burgess, MD
Pain Management and Substance Use Disorders: JCPP Strategic Session
State Response to Opioids and Infectious Disease
Impact of Policy and Regulatory Responses to the Opioid Epidemic on the Care of People with Serious Illness Hemi Tewarson, Director, Health Division National.
Medically assisted treatment
National and State Data
Presentation transcript:

Public Health Conference March 3, 2016

 Recognize the merger of opioid abuse and disease transmission  Identify Missouri opioid abuse data components  Describe an example of a community level intervention  Explain the approach of DHSS’ Rx Drug Misuse Workgroup

 Spring, 2015  First ever DHS action for public health needs  HIV and HCV outbreak in Indiana  First ever DHSS participation  Three Disease Intervention Specialists (DIS) deployed to Indiana

Broadway Blvd., Austin IN

 December, 2014 – 3 new HIV diagnoses in Austin, IN (Scott County)  January, more new HIV infections  Typically, fewer than five cases of HIV infection are reported annually in Scott Co, IN.

 February, Outbreak officially identified  Through efforts of a single DIS assigned to SE Indiana  March, Public Health Emergency declared in Scott County

 Implementation of Indiana Executive Order provided for:  Establishing an incident command center to coordinate HIV intervention and prevention, and substance abuse treatment  Free HIV testing & utilization of rapid HIV screening  Increased interviewing of newly identified positive persons to elicit needle sharing and sex partners  Referral to medical and HIV care

 Executive Order also:  Launched a medical clinic  Provided assistance for Healthy Indiana Plan Insurance applications  Created and implemented education and prevention messages, “You Are Not Alone”  Enacted a targeted, short-term needle exchange program for the sole purpose of containing the epidemic  Needle exchange programs are illegal in Indiana

One-Stop-Shop Flyer Needle Exchange Info Card April 4, Needle Exchange and One Stop Shop opened

Scott County One-Stop-Shop Needle Exchange Entrance

 February, State health officials announced that the number of HIV cases in the Southeastern Indiana outbreak is 188  The majority of cases were linked to syringe- sharing partners injecting the prescription opioid oxymorphone aka “Opana” For more Indiana Health Department updates see this link:

 As of June, 2016:  Total Individuals Participating: 189  Estimated Needles Brought In: 27,878  Includes needles supplied by the program and within the community  Total Needles Provided: 28,671 Source:

 491 IDU and sexual partners (contacts) elicited by DIS  46 unlocatable  16 other (out of jurisdiction, deceased, etc.) Source: Indiana Long-Term Planning Process Update

 408 contacts located and offered testing  21 refused testing  169 HIV positive  86% co-infected with HCV  145 HCV positive Source: Indiana Long-Term Planning Process Update

 Since 2010 Scott County has ranked 92 nd out of Indiana’s 92 counties in Health Outcomes*  Almost 19% of Scott County’s population live below the poverty line*  2014 unemployment rate 9.8%*  Austin, Indiana, the epicenter of the Outbreak in Scott County had a 25.8% unemployment rate** *Source: ** Source:

 Large rural, medically underserved areas  Limited needle exchange programs in MO (1 in KC)  Drug paraphernalia laws that include syringes  Requirement to Disclose (+)HIV infection statutes that carry legal penalties  Lack of opioid prescription tracking system  Increasing ED visits related to Intravenous Drug Use

Andrew Hunter, DHSS—Bureau of Health Care Analysis & Data Dissemination

Could the Indiana scenario happen in Missouri?

Data contributed by the Bureau of Vital Statistics

2014 Figures:  U.S. Rate=14.7  Missouri Rate=18.2 (tied for 14 th highest among all states)  Indiana Rate=18.2 Source: CDC, MMWR, Increases in Drug and Opioid Overdose Deaths — United States, 2000–2014 Reported rates are age-adjusted per 100,000 population

Opioid Rates: U.S. Rate = 7.5 Missouri Rate = 9.8 Heroin Rates U.S. Rate=1.8 Missouri Rate=3.7 Source: CDC Wonder Reported rates based on are age-adjusted per 100,000 population

Data contributed by the Bureau of Health Care Analysis and Data Dissemination

All inpatient/ER counts/rates in this presentation include only records with an opioid poisoning listed as the primary diagnosis on the discharge record.

Which groups in Missouri are most impacted by opioids?

Data presented on this slide is for non-Hispanic population only

Percent change values compare the rates to the rates.

These rates represent only non-Hispanic residents.

Percent change values compare the rates to the rates.

What areas of Missouri are most impacted?

Rate per 100,000 Population

Crude Rate per 100,000 Population

Crude Rate per 100,000 Population

Rate per 100,000 Population

Source: Riverfront Times and Missouri Hospital Association FY 2005 through FY 2014 inpatient and outpatient hospital discharge databases and Nielsen-Claritas 2014 PopFacts Premier. Z-scores calculated at the ZIP level using the rate of hospital visits between 2005 and 2014 per 10,000 residents. ZIPs with fewer than 50 residents were omitted.

 Missouri has high death and hospital utilization rates compared to national figures for opioids, especially heroin.  Rates are increasing in Missouri at a brisk pace. The 2014 opioid death rate is nearly 5 times higher than the 2001 rate. The heroin death rate is 15 times higher.  Heroin rates are highest among males, African- Americans and younger adult age groups (18- 24, 25-34).

 Heroin rate increases are highest for whites of both genders and younger age groups.  High death and hospital utilization rates for non-heroin opioids are highest in the southeast and southwest areas of the state.  High heroin death and hospital utilization rates are clustered in the St. Louis area.

Rx Drug Misuse Workgroup Dean Linneman, Deputy Director, Division of Regulation and Licensure

Rx Drug Misuse Workgroup The Workgroup is a multi-agency, multi- association group. Participants include:

Rx Drug Misuse Workgroup Four-pronged approach to building a solution: Creation of a Rx Drug Monitoring Program Alleviating Rx Drug Misuse Rx Drug Monitoring Program

Rx Drug Misuse Workgroup

Four-pronged approach to building a solution: Increased Education and Awareness Rx Drug Monitoring Program Education Alleviating Rx Drug Misuse

Rx Drug Misuse Workgroup

Four-pronged approach to building a solution: Increased Treatment/Therapy Options Education Rx Drug Monitoring Program Treatment and Therapy Options Alleviating Rx Drug Misuse

Rx Drug Misuse Workgroup Medication-Assisted Treatment  Medication-Assisted Treatment (MAT) is treatment for opioid addiction that uses medications such as methadone or buprenorphine to treat addiction to short-acting opioids, such as heroin, morphine and codeine, as well as synthetic opioids, including oxycodone, OxyContin®, and hydrocodone.

Rx Drug Misuse Workgroup Medication-Assisted Treatment  Methadone, when used in MAT can only be dispensed (not prescribed) in an Opioid Treatment Program (OTP). o (  Office-based treatment for opioid addiction using buprenorphine is available from physicians who meet certain qualifications.

Rx Drug Misuse Workgroup Four-pronged approach to building a solution: Pain Clinic Regulation Rx Drug Monitoring Program Education Pain Clinic Regulation Treatment and Therapy Options Alleviating Rx Drug Misuse

Rx Drug Misuse Workgroup Pain Clinic Regulation

Rx Drug Misuse Workgroup Alleviating Rx Drug Misuse Treatment and Therapy Options Rx Drug Monitoring Program Education Pain Clinic Regulation The Final Product.

 Recognize the merger of opioid abuse and disease transmission  Indiana IDU linkage to HIV/HCV transmission  Identify Missouri opioid abuse data components  Missouri trends vs. national

 Describe an example of a community level intervention  KC Care Xchange  Explain the approach of DHSS’ Rx Drug Misuse Workgroup  Four-pronged effort